Authors:
VINCENTI F
LANTZ M
BIRNBAUM J
GAROVOY M
MOULD D
HAKIMI J
NIEFORTH K
LIGHT S
Citation: F. Vincenti et al., A PHASE-I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL-TRANSPLANTATION, Transplantation, 63(1), 1997, pp. 33-38
Citation: Ka. Nieforth et al., USE OF AN INDIRECT PHARMACODYNAMIC STIMULATION MODEL OF MX PROTEIN INDUCTION TO COMPARE IN-VIVO ACTIVITY OF INTERFERON ALFA-2A AND A POLYETHYLENE GLYCOL-MODIFIED DERIVATIVE IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 636-646
Authors:
MCKAY RSF
CARRITHERS JA
HARRIS S
MEYER JP
MOULD D
Citation: Rsf. Mckay et al., H-REFLEX AND DEEP TENDON REFLEX CHANGES DURING VARYING DOSES OF BUPIVACAINE USED FOR EPIDURAL ANALGESIA IN OBSTETRICS, Anesthesiology, 83(3A), 1995, pp. 948-948
Authors:
ANASETTI C
HANSEN JA
WALDMANN TA
APPELBAUM FR
DAVIS J
DEEG HJ
DONEY K
MARTIN PJ
NASH R
STORB R
SULLIVAN KM
WITHERSPOON RP
BINGER MH
CHIZZONITE R
HAKIMI J
MOULD D
SATOH H
LIGHT SE
Citation: C. Anasetti et al., TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR, Blood, 84(4), 1994, pp. 1320-1327